Search

Your search keyword '"Arrotti, S."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Arrotti, S." Remove constraint Author: "Arrotti, S."
31 results on '"Arrotti, S."'

Search Results

1. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

2. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

3. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

4. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

5. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

6. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

7. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

8. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

9. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

10. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

12. When the Coronary Anomaly Saves Your Life: a Very Rare Ischemic Coronary Presentation - Our Cardiac Catheterization Laboratory Experience and New Way of Treatment

13. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

14. Anatomical features and clinical correlations in Caucasian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy

15. Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction

16. Letter to the Editor, regarding Rakha S, Hammad A, Elmarsafawy H, Korkor MS, et al. (2023). A deeper look into the functions of right ventricle using three-dimensional echocardiography: the forgotten ventricle in children with systemic lupus erythematosus. Eur J Pediatr. 182:2807-2819.

17. Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications.

18. Effects of Ivabradine on Right Ventricular Systolic Function in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale.

19. Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study.

20. The Importance of Mehran Score to Predict Acute Kidney Injury in Patients with TAVI: A Large Multicenter Cohort Study.

21. Anthropometric parameters and radiation doses during percutaneous coronary procedures.

22. Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation.

24. Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes.

25. Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes.

27. Kidney dysfunction and short term all-cause mortality after transcatheter aortic valve implantation.

28. Complicated myocardial infarction in a 99-year-old lady in the era of COVID-19 pandemic: from the need to rule out coronavirus infection to emergency percutaneous coronary angioplasty.

29. Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction.

30. Coronary involvement in Churg-Strauss syndrome.

31. Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy.

Catalog

Books, media, physical & digital resources